James Kelly
Director of Finance/CFO presso NOVAVAX, INC.
Patrimonio netto: 63 502 $ in data 31/03/2024
Profilo
Attualmente, James Patrick Kelly ricopre la posizione di direttore finanziario, tesoriere e vicepresidente esecutivo di Novavax, Inc. È anche membro dell'Associazione dei responsabili finanziari delle bioscienze. Nella sua carriera passata ha ricoperto la posizione di direttore finanziario, tesoriere e vicepresidente esecutivo di Vanda Pharmaceuticals, Inc, direttore finanziario e vicepresidente esecutivo di Supernus Pharmaceuticals, Inc, direttore della pianificazione e delle operazioni di Biogen, Inc, direttore di Aetna, Inc e vicepresidente e controllore di MedImmune LLC. Il signor Kelly ha conseguito un MBA presso la Cornell University e una laurea presso l'Università del Vermont.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVAVAX, INC.
0.01% | 10/03/2024 | 13 285 ( 0.01% ) | 63 502 $ | 31/03/2024 |
Posizioni attive di James Kelly
| Società | Posizione | Inizio |
|---|---|---|
| NOVAVAX, INC. | Director of Finance/CFO | 16/08/2021 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Precedenti posizioni note di James Kelly
| Società | Posizione | Fine |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/08/2021 |
| VANDA PHARMACEUTICALS INC. | Director of Finance/CFO | 15/03/2020 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 01/12/2010 |
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2005 |
| AETNA | Corporate Officer/Principal | 01/06/2000 |
Formazione di James Kelly
| Cornell University | Masters Business Admin |
| University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Aetna, Inc. engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It offers benefits, products and services to individuals, employers, healthcare professionals, and producers. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT. | Health Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
- Borsa valori
- Insiders
- James Kelly
